Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, ...

An update from Targovax ASA ( ($GB:0RIS) ) is now available. Circio Holding ASA has announced a proposed rights issue to raise up to NOK 50 ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech ...

AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

Postharvest losses in fruits, particularly apples, are a significant global issue. New research sheds light on how the immune ...

LTS-101 is a one-time AAV gene therapy candidate intended to provide durable expression of the TPP1 enzyme in the central nervous system (CNS) of children with CLN2 diseaseFDA designations underscore ...

While duplicating Fido isn’t quite the ethical minefield that duplicating Uncle Fred would be, it does raise questions on ...

The market presents significant opportunities driven by high demand for biologics and protein therapeutics, as well as ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial to evaluate ARV-393 plus glofitamab as ...

Discover Stoke Therapeutics' promising RNA therapies and market outlook. Learn the risks and commercial potential before investing in STOK shares.

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...